Opendata, web and dolomites

StreptoMANIAC SIGNED

Cost and benefit of beta-lactam resistance in Streptococcus pneumoniae: interplay between the resistance determinants and the cell elongation/division components

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 StreptoMANIAC project word cloud

Explore the words cloud of the StreptoMANIAC project. It provides you a very rough idea of what is the project "StreptoMANIAC" about.

solely    pg    binding    affinity    conferring    function    modified    advantage    pathogens    peripheral    benefit    threat    nasal    genomics    sinusitis    bacteremia    global    play    public    pneumococcus    combination    domain    children    penicillin    regulate    normal    cytological    mutated    leaving    antibiotics    stages    scenario    mutations    fill    concentrated    majority    elderly    components    pbp1a    pneumonia    last    vaccines    gaps    altered    primarily    pbp2x    mediated    gram    biochemical    acquired    meningitis    health    division    streptococcus    unaffected    peptidoglycan    isolates    lactam    cavities    pbp2b    roles    drive    lactams    oral    resident    otitis    enzymes    positive    six    mechanisms    pbp    acquisition    enzyme    resistant    strains    techniques    pneumoniae    constitutes    biosynthesis    young    serious    genetic    transpeptidase    effect    listed    little    resistance    drug    cell    beta    pbps    despite    ciarh    discovery    whereas    wall    media    clinical    emergence    proteins    multiple   

Project "StreptoMANIAC" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITA DEGLI STUDI DI TRENTO 

Organization address
address: VIA CALEPINA 14
city: TRENTO
postcode: 38122
website: www.unitn.it

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Total cost 183˙473 €
 EC max contribution 183˙473 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2018
 Funding Scheme MSCA-IF-EF-CAR
 Starting year 2019
 Duration (year-month-day) from 2019-11-01   to  2021-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITA DEGLI STUDI DI TRENTO IT (TRENTO) coordinator 183˙473.00

Map

 Project objective

The widespread emergence of acquired resistance to antibiotics constitutes a serious threat to global public health. Among Gram-positive pathogens, Streptococcus pneumoniae (the pneumococcus) is a normal resident of the oral and nasal cavities but is also cause of otitis media and sinusitis as well as pneumonia, bacteremia and meningitis, particularly in young children and the elderly. Despite the availability of effective vaccines, S. pneumoniae remains an important clinical problem, also because of the increase of multi-drug resistant clinical isolates. S. pneumoniae is, indeed, listed by the WHO as one of the priority pathogens to drive research, discovery and development of new antibiotics. In S. pneumoniae, resistance to beta-lactam antibiotics represents a highly complex scenario, involving both target enzymes, the penicillin-binding proteins (PBPs), and non-PBP components, as the two-component system CiaRH. In clinical isolates, beta-lactam resistance is primarily mediated by the acquisition of multiple mutations in the transpeptidase domain of three of its six PBPs: PBP2x, PBP2b and PBP1a. These modified PBPs have reduced affinity for beta-lactams while leaving the enzyme function unaffected, thus conferring an advantage for the mutated strains in the presence of the antibiotics. However, PBPs are not only the beta-lactam target but are also essential enzymes involved the last stages of peptidoglycan biosynthesis, where they play specific roles in peripheral (side-wall) growth and cell division. Whereas the majority of studies so far concentrated solely on the effect of altered PBPs on resistance, little is known about the impact of the altered PBPs on PG biosynthesis, cell growth and division. Using a combination of genetic, biochemical, cytological and comparative genomics techniques, this study aims to fill in the knowledge gaps in the cost and benefit of acquired beta-lactam resistance in S. pneumoniae and in the complex mechanisms that regulate it.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "STREPTOMANIAC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "STREPTOMANIAC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

COLEX (2019)

Coopetition and Legislation in the Spanish Netherlands (1598-1665)

Read More  

EPIC (2019)

Evolution of Planktonic Gastropod Calcification

Read More  

iRhomADAM (2020)

Uncovering the role of the iRhom2-ADAM17 interaction in inflammatory signalling

Read More